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Acute Urinary Bladder Distension Triggers
ICAM-1-mediated Renal Oxidative Injury via
the Norepinephrine–renin–angiotensin II
System in Rats
Show-Shing Chen,1† Wang-Chuan Chen,2,3† Satoshi Hayakawa,2,3 Ping-Chia Li,4* Chiang-Ting Chien5*
Background/Purpose: Acute urinary bladder distension (AUBD) can activate bladder mechanical afferent
and renal sympathetic nerves, which contributes to renal vasoconstriction. We hypothesized that AUBD-
induced renal sympathetic activation may contribute to inflammatory responses and end-organ damage
via activation of angiotensin-II-receptor-mediated intercellular adhesion molecule-1 (ICAM-1) expression
and leukocyte infiltration in the kidney.
Methods: We evaluated the effect of 2 hours of AUBD induced by a threshold volume (micturition vol-
ume) on renal oxygen tension, microcirculation, renal reactive oxygen species (ROS) and monocyte/
macrophage (ED-1) infiltration, and ICAM-1 expression in the kidneys of urethane-anesthetized female
Wistar rats. Bilateral ureteral dissection, renal denervation and intrarenal angiotensin II type 1 receptor
blockade (2 mg/kg valsartan) were used to determine their roles in AUBD-induced renal oxidative stress.
Results: Our results showed that AUBD evoked hypertension, a reduction in cortex oxygen tension and
microcirculation, and increased renal ROS production, which were caused by increased perivascular and
interstitial monocyte/macrophage infiltration and endothelial ICAM-1 overexpression. Renal denervation
and angiotensin II type 1 receptor antagonist, but not bilateral ureter dissection, abolished the reduction
in cortex oxygen tension and microcirculation, increased renal ROS production, increased perivascular
monocyte/macrophage infiltration, and led to endothelial ICAM-1 overexpression in the kidney.
Conclusion: Acute urinary retention enhances renal sympathetic activity, which causes renal vasoconstric-
tion and increases oxidative stress, adhesion-molecule expression and leukocyte infiltration in the rat kid-
ney via the angiotensin II type 1 receptor pathway. [J Formos Med Assoc 2009;108(8):627–635]
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Acute urinary bladder distension (AUBD) with
excessive stimulation of low- and high-threshold
mechanical afferents in the over-distended urinary
bladder may lead to pathophysiological stress1
and evoke a sympathetic-nerve-mediated vesico-
vascular reflex. This may lead to hypertension,
tachycardia, vasoconstriction, and functional im-
pairment of the heart, kidney, and liver.2–4 A pos-
sible pathway, norepinephrine–renin–angiotensin
II axis by sympathetic activation, may be involved
in the AUBD-induced injury.
Our previous study showed that AUBD pro-
motes reactive oxygen species (ROS) production
and enhances expression of proinflammatory nu-
clear factor-κB (NF-κB), activator protein-1 (AP-1),
and intercellular adhesion molecule-1 (ICAM-1).4
AUBD also promotes proapoptotic mechanisms,
including increases in the Bax/Bcl-2 ratio, cas-
pase-3 expression, poly-(ADP-ribose)-polymerase
cleavage, and DNA fragmentation and apoptotic
cells in the liver.4 Renal sympathetic activation
significantly increases the secretion of norepi-
nephrine, angiotensin II, adenosine, and adeno-
sine metabolites (inosine, hypoxanthine and
xanthine).5 The increased release of these sub-
stances may induce oxidative stress and lead to
oxidative injury in end-organs such as the kid-
ney.6–8 For example, increased norepinephrine
enhances endothelial ROS production, which con-
tributes to endothelial dysfunction and apopto-
sis.6,8 Increased angiotensin II induces vascular
and glomerular damage, leukocyte infiltration,
ICAM-1 overexpression, and expression of renal
nitrotyrosine and 8-hydroxydeoxyguanosine in
the kidneys.7 The increase in angiotensin II can
increase renovascular resistance, inflammatory
response and renal injury, mainly via activation
of the angiotensin II type 1 (AT1), but not type 2
receptors.9 We suggest that AUBD induces renal
oxidative injury via a renal-nerve-mediated AT1
pathway.
Materials and Methods
Animals
Female Wistar rats (200–250 g) were housed at
the Experimental Animal Center, National Taiwan
University, at a constant temperature and with a
consistent light cycle (light from 07.00 to 18.00
hours). Food and water were provided ad libitum.
All surgical and experimental procedures were
approved by the Institutional Animal Care and
Use Committee of National Taiwan University
College of Medicine and College of Public Health,
and were conducted in accordance with the guide-
lines of the National Science Council of the
Republic of China (1997). All efforts were made
to minimize animal suffering and the number of
animals used throughout the experiment.
AUBD
Rats were anesthetized with subcutaneous ure-
thane (1.2 g/kg). The body temperature was kept
at 37.0°C by an infrared light. PE-50 catheters
were placed in the left carotid artery for measure-
ments of heart rate and arterial blood pressure by
an ADI system (PowerLab/16S; ADI Instruments,
Castle Hill, NSW, Australia) with a transducer
(P23 1D; Gould–Statham, Quincy, MA, USA),
and in the left femoral vein for administration of
anesthetics when needed. At the end of each ex-
periment, the animals were sacrificed with an 
intravenous injection of potassium chloride. A
PE-50 tube was inserted into the bladder through
the urethra and tied in place with a ligature around
the urethral meatus.2,4 The catheter was connected
to a P23 1D pressure transducer and an infusion
pump (Infors AG, Bottmingen, Switzerland) via
a T-tube connector. The bladder volume was in-
creased by a steady infusion of 0.9% saline
(0.10 mL/minute) via the infusion pump.1,2,4
AUBD was established by infusing saline into the
urinary bladder until a threshold volume was
reached, which triggered active bladder contrac-
tions (> 20 mmHg in amplitude).1,2,4 Bladder 
infusion was then stopped and AUBD was main-
tained for 2 hours. To evaluate the role of the
ureters, renal nerves and AT1 receptors on renal
hemodynamics and oxidative stress, we cut both
ureters, and performed renal denervation1 and
AT1 receptor blockade via intrarenal administra-
tion of 2 mg/kg valsartan. The bladder pressure
was recorded continuously by the pressure trans-
ducer. The bladder was emptied by drainage of
the fluid via the transurethral catheter. These 
results were reproducible three times in each rat.
There were five rats in each group.
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Measurement of cortex oxygen tension 
and microvascular blood flow
We monitored oxygen tension in the cortex and
renal microvascular blood flow in response to
AUBD, at the same location as described by Jordan
et al10 and in our previous study.1 Fiberoptic mi-
croprobes that combined a laser Doppler system
and a thermocouple were inserted using a micro-
manipulator into the renal cortex. Renal cortex mi-
crocirculation measurements were performed at a
depth of 2 mm from the renal surface. Data were
collected continuously at 10-second intervals be-
fore, during, and after AUBD stimulation, and were
recorded to disk with the use of a data-acquisition
ADI system.
In vivo ROS recording
ROS generation in response to ischemia/reperfu-
sion injury was measured on the kidney surface by
intrarenal arterial infusion of a superoxide anion
probe, 2-methyl-6-(4-methoxyphenyl)-3,7-dihy-
droimidazo-[1,2-a]-pyrazin-3-one-hydrochloride
(MCLA) (0.2 mg/mL/hour; TCI-Ace; Tokyo Kasei
Kogyo Co. Ltd., Tokyo, Japan) and recorded by a
chemiluminescence analyzing system (CLD-110;
Tohoku Electronic Industrial Co. Ltd., Sendai,
Japan).1,2 The real-time displayed chemilumines-
cence signal was recognized as ROS level on the
kidney surface.
NADPH oxidase assay
The NADPH oxidase capacity of kidney tissue
samples was determined by using a lucigenin-
amplified chemiluminescence assay, the most
sensitive method of superoxide detection, which
measures NADPH-oxidase-mediated ROS gener-
ation.11 Kidney tissue samples were homogenized
with a mortar and pestle, under liquid nitrogen,
in three volumes of phosphate-buffered saline
(PBS) that contained 10 mM Tris, pH 7.4, and
1 mM EDTA. The homogenates were allowed to
thaw on ice, and NADPH oxidase capacity, an in-
dicator of oxidative stress, was measured imme-
diately by mixing 50 μL homogenate with 950 μL
reaction mix (PBS that contained 5 μM lucigenin,
2 mM CaCl2, and 100 μM NADPH) in the dark.
Chemiluminescence counts were integrated over
a 10-second period from the time of the addition
of 100 μM NADPH to a plateau, with a chemilu-
minescence analyzing system (CLD-110; Tohoku
Electronic Industrial Co. Ltd.).
Myeloperoxidase (MPO) assay
Tissue MPO activity, an enzyme marker of inflam-
mation and neutrophil infiltration, can be used
as a marker for neutrophil content.12 Renal tissue
samples were assayed for MPO as described previ-
ously,13 with minor modifications. Approximately
20 mg of tissue was homogenized on ice with a tis-
sue homogenizer (Biohomogenizer M133/1281-0;
Biospec Products, Inc., Bartlesville, OK, USA) in
4 mL ice-cold 5 mM phosphate buffer, pH 6.0. The
homogenate was centrifuged at 30,000g for 30
minutes at 4°C. The supernatant was discarded,
the pellet was resuspended in phosphate buffer,
and the homogenization procedure was repeated.
The second pellet was washed three times with ice-
cold 5 mM phosphate buffer, pH 6.0, and then
re-solubilized in 10 volumes of ice-cold 0.5% hexa-
decyltrimethylammonium bromide in 50 mM
phosphate buffer, by sonication on ice at full power
for 10–15 seconds (UP200S; Hielscher Ultrasound
Technology, Teltow, Germany). Sonication was re-
peated four times with 30 seconds cooling on ice
between bursts. The extract was then incubated
at 4°C for 20 minutes and was centrifuged at
12,500g for 15 minutes at 4°C. MPO activity in
the supernatant was assayed in a 96-well microtiter
plate, by mixing 20μL of supernatant (either undi-
luted or diluted 1:2, 1:5, and 1:10 with 50 mM
phosphate, pH 6.0) with 80 μL of assay buffer
(80 mM phosphate buffer, pH 5.4, 0.48 mg/mL
tetramethylbenzidine, and 0.001% hydrogen per-
oxide). The change in absorbance was measured
with a DU 640B spectrophotometer (Beckman
Coulter, Fullerton, CA, USA) over 3 minutes, and
1 U MPO activity was defined as that which de-
graded 1 μmol hydrogen peroxide per minute.
Morphological examination of renal tissue
We considered that AUBD-enhanced renal ROS
may have resulted from the increased ICAM-1 
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expression and monocyte/macrophage (ED-1)
infiltration. The rats (n = 3 in each group) were
sacrificed at the end of experiment. Tissue sections
in 10% formalin were incubated overnight at 4°C
with a mouse anti-rat antibody to ED-1 (CD68,
1:200; Serotec, Sydney, NSW, Australia) and
ICAM-1 (R&D Systems, Minneapolis, MN, USA)
at a dilution of 1:50. A biotinylated secondary an-
tibody (Dako, Botany, NSW, Australia) was then
applied, followed by streptavidin conjugated to
horseradish peroxidase (Dako). The chromogen
used was Dako liquid diaminobenzene. Twenty
high-power (400×) fields were selected randomly
for each kidney section, and the number of ED-1-
positive cells in the kidney and ICAM-1 expres-
sion in the renal arterial endothelium of vascular
rings were analyzed and photographed using a
Leica microscope (model DMRD; Leica Micro-
systems Gmbh, Wetzlar, Germany). The percent-
age of ICAM-1 expression in the vascular ring was
calculated as follows:
Statistical analysis
Differences within groups were evaluated by
paired t tests. One-way analysis of variance was
used for examining differences among groups.
Intergroup comparisons were made with Duncan’s
multiple-range test. Statistical significance was
assumed when p < 0.05.
Results
Our previous studies have indicated that mech-
anoreceptor activation in the urinary bladder en-
hances adrenal, renal and hepatic sympathetic
nerve activity, which leads to tachycardia, hyper-
tension, and a reduction in renal and hepatic he-
modynamics.2,4 In response to AUBD in the
current study, an increase in arterial blood pres-
sure (25 ± 2 mmHg) and bladder pressure (39 ±
5 mmHg), and a significant decrease (p < 0.05) in
renal cortex oxygen tension (from 45 ± 3 mmHg
to 12 ± 2 mmHg) and cortex microcirculation
(from 100 ± 0% to 18 ± 4%) are demonstrated in
Figure 1. Renal denervation, but not bilateral
ureteral dissection, abolished the decreased renal
cortex oxygen tension and microcirculation,
which indicated a direct effect of the renal nerves
on renal hemodynamics.
We determined the role of the norepineph-
rine–renin–angiotensin system in renal ROS pro-
duction, MPO activity, NADPH oxidase activity,
monocyte/macrophage infiltration and ICAM-1
expression in the kidney, by renal denervation,
bilateral ureter dissection, and intrarenal AT1 
receptor blockade (valsartan) pretreatment. We
found that the amount of renal ROS increased
gradually during AUBD stimulation, and reached
a high level during 30–40 minutes of AUBD
stimulation in the kidney with bilateral ureteral
dissection (Figures 2 and 3). The increase in renal
ROS that was associated with increased MPO–
NADPH oxidase activity was reduced by renal
denervation and valsartan (Figure 3), but not bi-
lateral ureteral dissection. Six hours after 2 hours
of AUBD stimulation, ICAM-1 expression was
increased significantly in the renal arterial en-
dothelium that was subjected to AUBD stimula-
tion (Figure 4E), which increased interstitial and
perivascular monocyte/macrophage infiltration
(Figure 4B). Renal denervation and AT1 receptor
blockade with valsartan significantly amelio-
rated AUBD-induced perivascular and interstitial
monocyte/macrophage infiltration (Figures 4C
and 4G) and decreased ICAM-1 expression (Figures
4F and 4H).
Discussion
Several previous1–4 studies and the current study
have shown that AUBD induced by complete or
partial bladder outlet obstruction or acute urine
retention increases bladder pressure, which en-
hances bladder pelvic afferent mechanoreceptor
activity and systemic activation of sympathetic
tone to the cardiovascular system, heart, liver and
kidney. A previous study3 in humans has indicated
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that urinary bladder distension at a range around
mean intravesical pressure of 20 mmHg reduces
coronary circulation in patients with early athero-
sclerosis via sympathetic activation through α1
adrenergic receptors. Intravesical pressure of
20 mmHg was selected because the intravesical
pressures were at least 17 mmHg in subjects with
normal bladder function during micturition.3 In
human liver, acute urinary retention also decreases
portal venous blood flow by 30–40%.4 In the
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Figure 1. (A) Effects of unilateral ureteral dissection (UX) on acute-urinary-retention-induced responses in arterial blood
pressure (ABP), intravesical pressure (IVP), cortex oxygen tension (PO2) and cortex microvascular blood flow (MVBF dis-
played in blood flow per unit, BPU) in the left kidney of the urethane-anesthetized rat. During retention, increased IVP
significantly elevated ABP and reduced cortex PO2 and MVBF. During retention, bilateral UX did not affect the reduction
of cortex PO2 and MVBF. (B) Effects of unilateral renal nerve denervation (RX) on acute-urinary-retention-induced re-
sponses in ABP, IVP, cortex PO2 and MVBF (displayed in BPU) in the left kidney of the urethane-anesthetized rat. During
retention, increased IVP significantly elevated ABP and reduced cortex PO2 and MVBF. During retention, RX treatment
abolished the reduction of cortex PO2 and MVBF.
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present study, AUBD via renal sympathetic acti-
vation evoked a reduction in renal cortex oxygen
tension and microcirculation, which led subse-
quently to enhanced renal ROS production by
the increased endothelial ICAM-1 expression and
monocyte/macrophage infiltration. Acute urinary-
retention-induced renal vasoconstriction was
mediated by activation of the norepinephrine–
renin–angiotensin II system.2 Our study showed
that renal denervation and the intrarenal AT1
receptor antagonist, but not bilateral ureteral dis-
section, abolished the renal vasoconstriction asso-
ciated with oxidative stress. Valsartan is a selective
AT1 receptor antagonist that may affect angioten-
sin II function via the balance between AT1 and
AT2 receptors. Valsartan may reduce AUBD-evoked
renal ROS production via inhibition of the renin–
angiotensin II system. Inhibition of the renin–
angiotensin system may protect the kidney against
hypertension- or ischemia/reperfusion-induced
injury. Additionally, AT2 receptor activation, but
not AT1 receptor blockade may also play an in-
direct role in reducing renal ROS production. 
We found profound perivascular or interstitial
monocyte/macrophage (ED-1) infiltration and
ICAM-1 overexpression in the renal vessel endo-
thelium in rat kidneys after AUBD stimulation.
The efficacy of renal nerve denervation and val-
sartan to ameliorate ED-1 levels, as well as endo-
thelial ICAM-1, indicates the involvement of
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Figure 2. Effects of (A) bilateral ureteral 
dissection (UX) and (B) renal denervation (RX)
pretreatment on acute-urinary-retention-evoked
renal reactive oxygen species (ROS) production 
in the left kidney. UX did not affect acute-
urinary-retention-elicited renal ROS production.
However, RX significantly inhibited acute-
urinary-retention-elicited renal ROS production 
in the left kidney. ABP = arterial blood 
pressure; IVP = intravesical pressure.
increased norepinephrine and angiotensin II re-
lease in AUBD-evoked oxidative stress. We suggest
that the use of valsartan in patients with AUBD,
to attenuate oxidative stress and inflammation,
requires further evaluation.
Endothelial dysfunction, inflammation and
oxidative stress have been linked to the patho-
genesis of cardiovascular and renal diseases.13–15
In spontaneously hypertensive rats, increased
norepinephrine production can enhance ROS pro-
duction by NADH/NADPH oxidase, which results
in the inactivation of nitric oxide and impairment
of endothelial modulation of vascular contrac-
tion.8 In neonatal rat endothelial cells, treatment
with norepinephrine increases intracellular ROS
level and extracellular signal-regulated kinase
(ERK), c-Jun N-terminal kinase, p38 phosphory-
lation, and apoptosis.16 Antioxidants such as 
vitamin C and N-acetylcysteine inhibit norepi-
nephrine-induced oxidative injury and ERK, c-Jun
N-terminal kinase, p38 phosphorylation, and
apoptotic cell death.6 Angiotensin II-induced renal
damage is associated with perivascular inflamma-
tion and increased oxidative stress. Entacapone,
a catechol-O-methyltransferase inhibitor, pro-
vides protection against angiotensin-II-induced
renal damage, through antioxidative and anti-
inflammatory mechanisms.7
On the other hand, the mechanism by which
AUBD promotes leukocyte adhesion is also pos-
sibly by substance-P-enhanced expression of
ICAM-1 in the kidney and blood vessels. Reed 
et al showed that intraperitoneal administration
of a non-peptide neurokinin-1 receptor (NK-1R)
antagonist inhibits adhesion formation in a rat
model.17,18 Since the proinflammatory peptide
substance P, the best-characterized NK-1R ligand,
can induce leukocyte adhesion and ROS genera-
tion,19 it follows that the NK-1R antagonist will
reduce ROS formation. Substance P is known to
induce ICAM-1 and vascular cell adhesion mole-
cule expression in endothelial and epithelial cells,
which leads to increased extravasation of leuko-
cytes.20 Substance P is also known to increase
leukocyte ROS generation.13 In our study, the en-
hanced levels of renal ROS, MPO activity and
NADPH oxidase activity were decreased by renal
denervation and AT1 receptor blockade, which
indicates the efficacy of valsartan in reduction of
renal ROS. Whether AUBD evokes oxidative in-
jury via substance-P-mediated ROS production
in the kidney requires further study.
In summary, the present study indicates 
that AUBD activates the norepinephrine–renin–
angiotensin II system and evokes oxidative injury
and an inflammatory response in the kidney.
Renal denervation or valsartan treatment blocks
the renin–angiotensin II system, which leads to
attenuation of AUBD-induced oxidative injury
and inflammation in the kidney.
Bladder distension induces kidney injury
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Figure 3. Effect of acute urinary bladder distension (AUBD)
on reactive oxygen species (ROS), myeloperoxidase (MPO)
and NADPH oxidase activity detection in the rat kidney.
The enhanced ROS (A), MPO (B) and NADPH oxidase ac-
tivity (C) was significantly higher in the AUBD kidney. The
enhanced renal ROS amounts, MPO activity and NADPH
oxidase activity are decreased by renal denervation (RX)
and angiotensin II type 1 receptor blockade (AR1), but not
by bilateral ureter dissection (UX). Data are expressed as
mean ± standard error of the mean (n = 6 in each group).
*p < 0.05 vs. C group; †p < 0.05 vs. AUBD group.
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